Anhui Huaren Health Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Anhui Huaren Health Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 52.8%. Its total assets and total liabilities are CN¥5.0B and CN¥2.9B respectively. Anhui Huaren Health Pharmaceutical's EBIT is CN¥195.7M making its interest coverage ratio 12.1. It has cash and short-term investments of CN¥1.2B.
Key information
52.8%
Debt to equity ratio
CN¥1.07b
Debt
| Interest coverage ratio | 12.1x |
| Cash | CN¥1.20b |
| Equity | CN¥2.02b |
| Total liabilities | CN¥2.94b |
| Total assets | CN¥4.96b |
Recent financial health updates
Recent updates
These 4 Measures Indicate That Anhui Huaren Health Pharmaceutical (SZSE:301408) Is Using Debt Extensively
Aug 07
Anhui Huaren Health Pharmaceutical's (SZSE:301408) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 07Returns On Capital Signal Tricky Times Ahead For Anhui Huaren Health Pharmaceutical (SZSE:301408)
Mar 25Financial Position Analysis
Short Term Liabilities: 301408's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥2.2B).
Long Term Liabilities: 301408's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥769.0M).
Debt to Equity History and Analysis
Debt Level: 301408 has more cash than its total debt.
Reducing Debt: 301408's debt to equity ratio has increased from 28.8% to 52.8% over the past 5 years.
Debt Coverage: 301408's debt is well covered by operating cash flow (20.4%).
Interest Coverage: 301408's interest payments on its debt are well covered by EBIT (12.1x coverage).